Invesco QQQ, CoreWeave, Cidara Therapeutics, ProShares UltraPro Short QQQ, and Circle Internet Group are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value...
MarketBeat·17h ago
More News
Medical Stocks To Watch Today - November 15th
Eli Lilly and Company, Cidara Therapeutics, UnitedHealth Group, Pfizer, and Metsera are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are...
MarketBeat·18h ago
Cidara Therapeutics (NASDAQ:CDTX) Sets New 12-Month High - Here's Why
Cidara Therapeutics (NASDAQ:CDTX) Sets New 52-Week High - Still a Buy...
MarketBeat·21h ago
Cidara Therapeutics Sees Unusually Large Options Volume (NASDAQ:CDTX)
Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) was the recipient of unusually large options trading activity on Friday. Investors bought 15,470 call options on the stock. This represents...
MarketBeat·22h ago
Top Value Stocks To Watch Now - November 14th
Invesco QQQ, CoreWeave, Cidara Therapeutics, ProShares UltraPro Short QQQ, Circle Internet Group, Nebius Group, and Metsera are the seven Value stocks to watch today, according to MarketBeat's stock...
MarketBeat·2d ago
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their...
PR Newswire·2d ago
Cidara Therapeutics Shares Soar 105% After Merck Agrees To $9.2B Takeover Deal
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) climbed 105.68% to $217.99, up $112.00, after it announced that Merck & Co. will acquire all outstanding shares for $221.50 per share in cash, valuing the...
Nasdaq News: Markets·2d ago
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher
read more...
Benzinga·2d ago
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Cidara...
PR Newswire·2d ago
Merck Makes Big Bet On Flu Protection With Cidara Buyout
Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.read more...